COA Principal ScientistNovo Nordisk A/S, Søborg, DenmarkSøborg, Hovedstaden, Denmark
PB0635 - A usability study assessing handling and preference of the concizumab pen-injector in patients with haemophilia and caregivers
Monday, June 26, 202318:30 – 19:30 ET
OC 59.4 - Health-related quality of life, treatment burden and patient preference in patients with haemophilia A/B without inhibitors on concizumab prophylaxis: results from the phase 3 explorer8 study
Tuesday, June 27, 202315:30 – 15:45 ET
